Davidson Scott, Kirsner Steven, Mason Bryan, Kisling Kelly, Barrett Renee D, Bonetati Anthony, Ballo Matthew T
Department of Radiation Oncology, The University of Texas Medical Branch, Galveston, Texas.
Department of Radiation Physics, The University of Texas M. D. Anderson Cancer Center, Houston, Texas.
Pract Radiat Oncol. 2015 Sep-Oct;5(5):e499-e504. doi: 10.1016/j.prro.2015.02.011. Epub 2015 Apr 6.
To determine the setup error on an electron breast boost technique using daily cone beam computed tomography (CBCT). Patient and setup attributes were studied as contributing factors to the accuracy.
Reproducibility of a modified lateral decubitus position breast boost setup was verified for 33 patients using CBCT. Three-dimensional matching was performed between the CBCT and the initial planning CT for each boost fraction by matching the tumor bed and/or surgical clips. The dosimetric impact of the daily positioning error was achieved by rerunning the initial treatment plans incorporating the recorded shifts to study the dose differences. Breast compression, decubitus angle, tumor bed location and volume, and cup size were studied for their contribution to setup error.
The range of setup errors was: 1.5 cm anterior to 9 mm posterior, 1.3 cm superior to 2.3 cm inferior, and 3.2 cm medial to 2.4 cm lateral. Seven patients had setup errors that were ≥2-cm margin placed on the tumor bed and scar. Four of those 7 patients had unacceptable coverage as defined by the volume of the tumor bed plus scar that is covered by the 90% isodose line (V90) compared with the original plan. All other patients had no discernible difference in the coverage (V90). The use of compression, tumor bed location, or volumes >20 mL showed no effect on coverage.
In general, this study supported that a 2-cm margin was adequate (29 of 33 patients) when patients are treated under typical conditions. Care should be taken when high electron energies are selected because the coverage at depth is more difficult to maintain in the clinical environment.
使用每日锥形束计算机断层扫描(CBCT)确定电子乳腺瘤床补量技术中的摆位误差。研究患者及摆位属性作为影响准确性的因素。
使用CBCT对33例患者改良侧卧位乳腺瘤床补量摆位的可重复性进行验证。通过匹配瘤床和/或手术夹,在每次补量分次时对CBCT与初始计划CT进行三维匹配。通过重新运行纳入记录移位的初始治疗计划以研究剂量差异,从而得出每日定位误差的剂量学影响。研究乳腺压迫、卧位角度、瘤床位置和体积以及罩杯尺寸对摆位误差的影响。
摆位误差范围为:前后方向上,向前1.5 cm至向后9 mm;上下方向上,向上1.3 cm至向下2.3 cm;内外方向上,向内3.2 cm至向外2.4 cm。7例患者的摆位误差在瘤床和瘢痕处产生了≥2 cm的边界。在这7例患者中,有4例按照90%等剂量线覆盖的瘤床加瘢痕体积(V90)定义,其覆盖情况与原计划相比不可接受。所有其他患者的覆盖情况(V90)无明显差异。使用压迫、瘤床位置或体积>20 mL对覆盖情况无影响。
总体而言,本研究支持在典型条件下治疗患者时,2 cm的边界是足够的(33例患者中的29例)。选择高电子能量时应谨慎,因为在临床环境中更难维持深部的覆盖情况。